On May 28, 2021 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will be holding a digital company presentation at the following virtual investor conference (Press release, Herantis Pharma, MAY 28, 2021, View Source,c3355594 [SID1234583257]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event Details: Redeye Investor Forum Online

Date: 2 June 2021

Presentation Time: 10:50 CEST / 11:50 EEST

The presentation will be available via a digital library, which is accessible to event participants only. Here you will find the registration link to register for the broadcast: View Source